Capital + Deals
Medtronic to acquire Cleveland medical tech leader SPR Therapeutics for $650 Million
The major medtech exit highlights a massive win for Northeast Ohio’s biomedical sector. By absorbing the homegrown leader in non-opioid pain therapies, the global healthcare giant secures an FDA-cleared, temporary device that alters how physicians treat chronic pain.